The concentration and type of monoclonal protein and their impact on clinical severity in patients with symptomatic myeloma
Abstract Background and objectives: Multiple Myeloma is a clonal plasma cell proliferation
in the bone marrow that produces abnormal monoclonal proteins in serum and/or urine that …
in the bone marrow that produces abnormal monoclonal proteins in serum and/or urine that …
[HTML][HTML] Outcome of response of multiple myeloma to induction treatment in Kurdistan region of Iraq
Background: Nowadays, the therapy of multiple myeloma (MM) has successful and hopeful
outcomes. Worldwide, various treatment regimens are prescribed by clinical hematologists …
outcomes. Worldwide, various treatment regimens are prescribed by clinical hematologists …
[PDF][PDF] Effectiveness of antiplatelet thromboprophylaxis in myeloma patients using immunomodulators in Kurdistan region-Iraq
NAS Al-Allawi, BM Safar, BK Abdulla… - Annals of the College of …, 2020 - iasj.net
Objective: To evaluate the effect of antiplatelet in preventing thrombosis in multiple myeloma
patients treated by immunomodulatory drugs. Methods: The study was conducted on one …
patients treated by immunomodulatory drugs. Methods: The study was conducted on one …